TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
St1 Biokraft Stockholm AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
12,737
|
10,749
|
12,470 |
Financial expenses |
3
|
0
|
51 |
Earnings before taxes |
3,694
|
2,103
|
2,501 |
EBITDA |
3,538
|
2,002
|
2,552 |
Total assets |
10,507
|
8,141
|
9,515 |
Current assets |
7,783
|
4,888
|
5,879 |
Current liabilities |
7,213
|
4,596
|
5,450 |
Equity capital |
3,295
|
3,545
|
4,065 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
31.4%
|
43.5%
|
42.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
29.0%
|
19.6%
|
20.1% |
Return on assets (ROA) |
35.2%
|
25.8%
|
26.8% |
Current ratio |
107.9%
|
106.4%
|
107.9% |
Return on equity (ROE) |
112.1%
|
59.3%
|
61.5% |
Change turnover |
1,956
|
-711
|
549 |
Change turnover % |
18%
|
-6%
|
5% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.